Purine derivatives for use as medicament and for use in treating neurodegenerative or neuro-inflammatory disorders
申请人:COMMISSARIAT À L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
公开号:US11472807B2
公开(公告)日:2022-10-18
Compound of formula (I)
and its addition salts with pharmaceutically acceptable acids, and methods in which an effective amount of the compound or any pharmaceutically acceptable salt thereof is administered (as a medicament) to an individual in need thereof.
式(I)化合物
及其与药学上可接受的酸的加成盐,以及向有需要的人施用有效量的该化合物或其任何药学上可接受的盐的方法(作为药物)。